Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Legislation Easing IPPS New Tech Add-On Criteria Anticipated This Year

This article was originally published in The Gray Sheet

Executive Summary

An updated version of the "Medicare Innovation Responsiveness Act of 2001" (HR 2973) likely will be introduced during the 108th Congress, AdvaMed says

You may also be interested in...



IPPS New Technology Add-On Payment Rate Sufficient – MedPAC Report

CMS should continue to apply strict criteria for new technologies to qualify for "add-on" payments under the hospital inpatient prospective payment system, according to 1MedPAC's March 2003 report

IPPS New Technology Add-On Payment Rate Sufficient – MedPAC Report

CMS should continue to apply strict criteria for new technologies to qualify for "add-on" payments under the hospital inpatient prospective payment system, according to 1MedPAC's March 2003 report

CMS Open Process At Work: APC Panel Adopts Society Proposal

The Coalition for the Advancement of Prosthetic Urology's suggestion to rearrange the APC assignments for prosthetic urology procedures in the hospital outpatient prospective payment system has received a favorable response from a CMS panel

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel